Literature DB >> 30921594

Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes.

Filip Bouckaert1, Louise Emsell2, Kristof Vansteelandt3, François-Laurent De Winter4, Jan Van den Stock4, Jasmien Obbels5, Annemieke Dols6, Max Stek6, Katarzyna Adamczuk7, Stefan Sunaert8, Koen Van Laere9, Pascal Sienaert5, Mathieu Vandenbulcke4.   

Abstract

BACKGROUND: Gray matter volume decrease, white matter vascular pathology and amyloid accumulation are age-related brain changes that have been related to the pathogenesis of late life depression (LLD). Furthermore, lower hippocampal volume and more white matter hyperintensities (WMH) may contribute to poor response to electroconvulsive therapy (ECT) in severely depressed older adults. We hypothesized that the accumulation of age-related brain changes negatively affects outcome following ECT in LLD.
METHODS: 34 elderly patients with severe LLD were treated twice weekly with ECT until remission. All had both 3T structural magnetic resonance imaging (MRI) and β-amyloid positron emission tomography (PET) imaging using 18F-flutemetamol at baseline. MADRS and MMSE were obtained weekly which included 1 week prior to ECT (T0), after the sixth ECT (T1), and one week (T2) after the last ECT as well as at four weeks (T3) and 6 months (T4) after the last ECT. We conducted a multiple logistic regression analysis and a survival analysis with neuroimaging measures as predictors, and response, remission and relapse as outcome variable.
RESULTS: We did not find any association between baseline hippocampal volume, white matter hyperintensity volume and total amyloid load and response or remission at 1 and 4 weeks post ECT, nor with relapse at week 4. LIMITATIONS: The present exploratory study was conducted at a single center academic hospital, the sample size was small, the focus was on hippocampal volume and the predictive effect of structural and molecular changes associated with aging were used.
CONCLUSIONS: Our study shows no evidence of relationship between response to ECT and age-related structural or molecular brain changes, implying that ECT can be applied effectively in depressed patients irrespective of accumulating age-related brain changes.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Amyloid; Electroconvulsive therapy; Hippocampal volume; Late life depression; Response; White matter hyperintensities

Mesh:

Year:  2019        PMID: 30921594     DOI: 10.1016/j.jad.2019.03.055

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

Review 1.  The Use of ECT in the Elderly-Looking Beyond Depression.

Authors:  Anthony N Chatham; Hadia Shafi; Adriana P Hermida
Journal:  Curr Psychiatry Rep       Date:  2022-07-13       Impact factor: 8.081

2.  The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression.

Authors:  Dore Loef; Kristof Vansteelandt; Mardien L Oudega; Philip van Eijndhoven; Angela Carlier; Eric van Exel; Didi Rhebergen; Pascal Sienaert; Mathieu Vandenbulcke; Filip Bouckaert; Annemiek Dols
Journal:  Brain Behav Immun Health       Date:  2021-11-16

3.  Is ECT a viable option to treat depression in older adults with bipolar disorder who are vulnerable to cognitive side effects?

Authors:  Machteld A J T Blanken; Mardien L Oudega; Sigfried N T M Schouws; Jeroen S van Zanten; Jennifer R Gatchel; William T Regenold; Annemiek Dols
Journal:  Bipolar Disord       Date:  2020-10-09       Impact factor: 6.744

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.